Although highest shortly after treatment initiation, the risk [of #ketoacidosis with #SGLT2 inhibitors] persists over time and should be evaluated throughout treatment. Patients should be instructed to pause treatment during acute illness and stress thelancet.com/journals/lan...
#T2D #DKA

#EndoSky

Although highest shortly after treatment initiation [with #SGLT2 inhibitors], the risk [of #ketoacidosis] persists over time and should be evaluated throughout treatment. Patients should be instructed to pause treatment during acute illness and stress www.thelancet.com/journals/lan...
#DKA #T2D

#Ketoacidosis risk with #SGLT2 inhibitors varies greatly by patient characteristics & is not confined to early in treatment. Risk should be assessed throughout treatment, & patients should be instructed to pause treatment during acute illness & stress www.thelancet.com/journals/lan...
#DKA #T2D

Empagliflozin (SGLT2 inhibitor) can cause euglycemic DKA. Recognize high anion gap metabolic acidosis and correct hypokalemia before giving insulin. #USMLE #SGLT2 #DKA

DKA management starts with fluids and a potassium check. Learn why low potassium changes the insulin plan—and why falling glucose alone does not mean DKA has resolved. #USMLE #DKA #Hypokalemia

#Ketoacidosis risk with #SGLT2 inhibitors varies greatly by patient characteristics and is not confined to early in treatment www.thelancet.com/journals/lan...
#DKA type 2 #diabetes #T2D

#MedSky #EndoSky

Risk of #ketoacidosis varies greatly by patient characteristics. As risk is not confined to shortly after treatment initiation, it should be considered throughout treatment, & patients should be instructed to pause therapy during acute illness & stress www.thelancet.com/journals/lan...
#DKA #SGLT2is